| 1 |
poly(lactic-co-glycolic acid)
(5647 times)
|
Pharmacology
(1431 times)
|
NPs (550 times)
PEG (233 times)
PLA (227 times)
|
1986 Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
|
| 2 |
polymorphous low-grade adenocarcinoma
(139 times)
|
Pathology
(43 times)
|
ACC (35 times)
PA (23 times)
MEC (12 times)
|
1988 Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study.
|
| 3 |
poly(L-glutamic acid)
(59 times)
|
Chemistry
(19 times)
|
PLL (17 times)
ASCs (6 times)
CS (6 times)
|
1984 Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
|
| 4 |
polyglycolic acid
(12 times)
|
Biomedical Engineering
(3 times)
|
PLLA (2 times)
ARI (1 time)
BMD (1 time)
|
2003 Comparative clinical study of connective tissue graft and two types of bioabsorbable barriers in the treatment of localized gingival recessions.
|
| 5 |
acid-polyglycolic acid copolymer
(7 times)
|
General Surgery
(2 times)
|
BM-MSCs (2 times)
NPs (2 times)
BMD (1 time)
|
2003 [Uptake of drug-containing nanoparticles in dog catotid and femoral arteries].
|
| 6 |
poly(alpha-L-glutamic acid)
(6 times)
|
Colloids
(3 times)
|
LB (2 times)
CD (1 time)
DHFR (1 time)
|
1989 Conformational transition of poly(alpha-L-glutamic acid). A polyelectrolytic approach.
|
| 7 |
poly(glycolide-co-lactide)
(5 times)
|
Biocompatible Materials
(2 times)
|
ADM (1 time)
Arg (1 time)
CS (1 time)
|
1997 Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
|
| 8 |
chitosan-poly(lactide-co-glycolide)
(4 times)
|
Biomedical Engineering
(2 times)
|
ALP (1 time)
BMP-2 (1 time)
CLSM (1 time)
|
2007 Homogeneous chitosan-PLGA composite fibrous scaffolds for tissue regeneration.
|
| 9 |
poly(co-glycolic lactic)acid
(4 times)
|
Biomedical Engineering
(2 times)
|
ALT (1 time)
DDS (1 time)
GMO (1 time)
|
2009 The influence of side group modification in polyphosphazenes on hydrolysis and cell adhesion of blends with PLGA.
|
| 10 |
Poly(LacticcoGlycolic)
(4 times)
|
Polymers
(1 time)
|
HA (2 times)
CIC (1 time)
|
2017 In Vitro and in Vivo Study of Poly(Lactic⁻co⁻Glycolic) (PLGA) Membranes Treated with Oxygen Plasma and Coated with Nanostructured Hydroxyapatite Ultrathin Films for Guided Bone Regeneration Processes.
|
| 11 |
acid-polyglycolic acid
(2 times)
|
Histology
(1 time)
|
PGA (1 time)
PLA (1 time)
|
2001 In vitro organization of biohybrid rat liver tissue incorporating growth factor- and hormone-releasing biodegradable polymer microcapsules.
|
| 12 |
dexamethasone-poly(d,l-lactide-co-glycolide)
(2 times)
|
Pharmacology
(2 times)
|
PBS (1 time)
|
2019 Dexamethasone Degradation in Aqueous Medium and Implications for Correction of In Vitro Release from Sustained Release Delivery Systems.
|
| 13 |
pediatric low-grade astrocytomas
(2 times)
|
Neoplasms
(2 times)
|
NF1 (1 time)
PFS (1 time)
|
2011 BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.
|
| 14 |
PLGA polymer solubilized in N-methyl pyrrolidone
(2 times)
|
Pharmacology
(1 time)
|
IM (1 time)
PVD (1 time)
|
2011 Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis.
|
| 15 |
poly(glycolic acid-co-dl-lactic acid)
(2 times)
|
Pharmacology
(2 times)
|
---
|
2000 In vitro and in vivo characterization of biodegradable enoxacin microspheres.
|
| 16 |
polyglycolic and polylactic acid
(2 times)
|
General Surgery
(2 times)
|
PLA (1 time)
PTH (1 time)
|
2003 Experimental study on the adhesion, migration and three-dimensional growth of Schwann cells on absorbable biological materials.
|
| 17 |
Polymorphous low-grade adenocarcinoma of salivary gland origin
(2 times)
|
Pathology
(1 time)
|
---
|
1999 Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland.
|
| 18 |
(PEG)-poly(d,l-lactic-co-glycolic) acid
(1 time)
|
Pharmacy
(1 time)
|
ART (1 time)
EE (1 time)
GA (1 time)
|
2020 Preparation, evaluation, and invitro cytotoxicity studies of artesunate-loaded glycyrrhetinic acid decorated PEG-PLGA nanoparticles.
|
| 19 |
(R-PLGA, equivalent to 1.03-1.72 mg/kg) or polymer microparticles alone
(1 time)
|
Pharmacology
(1 time)
|
Mtb (1 time)
|
2001 Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.
|
| 20 |
biotin-PEG-poly(lactic-co-(glycolic acid))
(1 time)
|
Biochemistry
(1 time)
|
PEG (1 time)
PLA (1 time)
PTMC (1 time)
|
2006 PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
|
| 21 |
deslorelin-poly(lactide-co-glycolide)
(1 time)
|
Pharmacology
(1 time)
|
HP-beta-CD (1 time)
|
2004 Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
|
| 22 |
lignin-graft-poly(lactic-co-glycolic) acid
(1 time)
|
Chemical Phenomena
(1 time)
|
ALGN (1 time)
FT-IR (1 time)
LGN (1 time)
|
2020 Lignin-Graft-Poly(lactic-co-glycolic) Acid Biopolymers for Polymeric Nanoparticle Synthesis.
|
| 23 |
nano-hydroxyapatite-polylactide- co-glycolide
(1 time)
|
Nanotechnology
(1 time)
|
MSC (1 time)
|
2011 Nanomaterials enhance osteogenic differentiation of human mesenchymal stem cells similar to a short peptide of BMP-7.
|
| 24 |
nanoparticle-poly(lactic-co-glycolic acid)
(1 time)
|
Pharmacology
(1 time)
|
---
|
1997 A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
|
| 25 |
paclitaxel-loaded polylactide-co-glycolide
(1 time)
|
Biomedical Engineering
(1 time)
|
---
|
2010 The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
|
| 26 |
particles were encapsulated into DL-lactide/glycolide copolymer
(1 time)
|
Pharmacology
(1 time)
|
BSA (1 time)
PLA (1 time)
SEM (1 time)
|
2005 Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release.
|
| 27 |
PEGylated-doxorubicin(DOX)-loaded-poly-lactic-co-glycolic acid
(1 time)
|
Chemical Phenomena
(1 time)
|
DOX (1 time)
DOXHCl (1 time)
IS (1 time)
|
2018 Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.
|
| 28 |
phenomenon, three commercially available D,L-lactic acid-co-glycolic acid
(1 time)
|
Pharmacology
(1 time)
|
ISFIs (1 time)
LA (1 time)
|
2008 Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior.
|
| 29 |
PLA-PEG and lactic acid--glycolic acid copolymer
(1 time)
|
General Surgery
(1 time)
|
BMP (1 time)
PLA-PEG (1 time)
|
1993 Bone induction and bone repair by composites of bone morphogenetic protein and biodegradable synthetic polymers.
|
| 30 |
PLA-PGA
(1 time)
|
|
GO (1 time)
nHA (1 time)
PCL (1 time)
|
2019 Synthetic Biodegradable Aliphatic Polyester Nanocomposites Reinforced with Nanohydroxyapatite and/or Graphene Oxide for Bone Tissue Engineering Applications.
|
| 31 |
PLGA group
(1 time)
|
Biocompatible Materials
(1 time)
|
---
|
2013 Preparation of porous PLGA/Ti biphasic scaffold and osteochondral defect repair.
|
| 32 |
PLGA scaffolds without cells
(1 time)
|
Dermatology
(1 time)
|
alpha-SMA (1 time)
FB (1 time)
GFP (1 time)
|
2017 Three-dimensional poly lactic-co-glycolic acid scaffold containing autologous platelet-rich plasma supports keloid fibroblast growth and contributes to keloid formation in a nude mouse model.
|
| 33 |
PLGA-Chi
(1 time)
|
Chemistry
(1 time)
|
alpha-T (1 time)
TRF (1 time)
|
2015 Cellular uptake, antioxidant and antiproliferative activity of entrapped alpha-tocopherol and gamma-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi).
|
| 34 |
PLGA-cRGD-PFH-ICG NPs
(1 time)
|
Biocompatible Materials
(1 time)
|
LIFU (1 time)
|
2020 Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi.
|
| 35 |
PLGA-CsA
(1 time)
|
Neoplasms
(1 time)
|
DOX (1 time)
FACS (1 time)
P-gp (1 time)
|
2014 Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors.
|
| 36 |
PLGA-DOX-CsA
(1 time)
|
Neoplasms
(1 time)
|
DOX (1 time)
FACS (1 time)
P-gp (1 time)
|
2014 Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors.
|
| 37 |
PLGA-fluvastatin
(1 time)
|
Dentistry
(1 time)
|
GBR (1 time)
|
2018 Generation and histomorphometric evaluation of a novel fluvastatin-containing poly(lactic-co-glycolic acid) membrane for guided bone regeneration.
|
| 38 |
PLGA-scaffolds
(1 time)
|
Medicine
(1 time)
|
ASCs (1 time)
SD (1 time)
|
2014 Periodontal tissue regeneration by transplantation of rat adipose-derived stromal cells in combination with PLGA-based solid scaffolds.
|
| 39 |
PLGA/GO
(1 time)
|
Biocompatible Materials
(1 time)
|
BDNF (1 time)
GO (1 time)
IGF-1 (1 time)
|
2019 Graphene oxide-PLGA hybrid nanofibres for the local delivery of IGF-1 and BDNF in spinal cord repair.
|
| 40 |
PLGA/PBMP
(1 time)
|
Biomedical Engineering
(1 time)
|
HA (1 time)
PBMP (1 time)
QS (1 time)
|
2019 Calcium-Binding Polymer-Coated Poly(lactide- co-glycolide) Microparticles for Sustained Release of Quorum Sensing Inhibitors to Prevent Biofilm Formation on Hydroxyapatite Surfaces.
|
| 41 |
PLGA4-7 LPNs
(1 time)
|
Biomedical Engineering
(1 time)
|
LPNs (1 time)
mRNA (1 time)
TT (1 time)
|
2018 Lipid Polymer Hybrid Nanomaterials for mRNA Delivery.
|
| 42 |
PLGAac
(1 time)
|
Chemistry
(1 time)
|
PCL (1 time)
|
2012 Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.
|
| 43 |
PLGAes
(1 time)
|
Chemistry
(1 time)
|
PCL (1 time)
|
2012 Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.
|
| 44 |
poly glycolic acid
(1 time)
|
Biomedical Engineering
(1 time)
|
PLLA (1 time)
|
2005 Biodegradable stents with elastic memory.
|
| 45 |
poly L-lactide/D-lactide/glycolide
(1 time)
|
General Surgery
(1 time)
|
CTGF (1 time)
GAG (1 time)
hUCMSCs (1 time)
|
2013 Effects of connective tissue growth factor on the regulation of elastogenesis in human umbilical cord-derived mesenchymal stem cells.
|
| 46 |
poly(alpha,L-glutamate)
(1 time)
|
Polymers
(1 time)
|
LC (1 time)
PHBG-P1 (1 time)
|
2001 Thermal and structural properties of biologically derived monodisperse hairy-rod polymers.
|
| 47 |
poly(D,L-lactide-co-glycolide) microparticles
(1 time)
|
Dentistry
(1 time)
|
ACS (1 time)
DBM (1 time)
rhBMP-2 (1 time)
|
1996 Periodontal repair in dogs: evaluation of rhBMP-2 carriers.
|
| 48 |
poly(glutamic acid)
(1 time)
|
Chemistry
(1 time)
|
PLL (1 time)
|
2010 Polyelectrolyte brushes studied by surface forces measurement.
|
| 49 |
poly(glycolide)-based
(1 time)
|
Biomedical Engineering
(1 time)
|
CMs (1 time)
PLLA (1 time)
SEM (1 time)
|
2005 Electrospun fine-textured scaffolds for heart tissue constructs.
|
| 50 |
poly(glycolide-co-lactide) copolymer
(1 time)
|
Biomedical Engineering
(1 time)
|
PGA (1 time)
PLA (1 time)
|
2009 Preparation of biodegradable PLA/PLGA membranes with PGA mesh and their application for periodontal guided tissue regeneration.
|
| 51 |
poly(lactic-co-glycolic acid) microparticles
(1 time)
|
Biomedical Engineering
(1 time)
|
CPCs (1 time)
GMPs (1 time)
|
2019 Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regeneration.
|
| 52 |
poly(lactic-co-glycolic acid)/fibrin gel
(1 time)
|
Orthopedics
(1 time)
|
IVD (1 time)
PG (1 time)
|
2017 Effects of annulus defects and implantation of poly(lactic-co-glycolic acid) (PLGA)/fibrin gel scaffolds on nerves ingrowth in a rabbit model of annular injury disc degeneration.
|
| 53 |
Poly(lactic-co-glycolic acid):Poly(ethylene oxide)
(1 time)
|
Biomedical Engineering
(1 time)
|
PEO (1 time)
|
2016 Hybrid Randomly Electrospun Poly(lactic-co-glycolic acid):Poly(ethylene oxide) (PLGA:PEO) Fibrous Scaffolds Enhancing Myoblast Differentiation and Alignment.
|
| 54 |
poly-L: -lactate-glycolic acid copolymer
(1 time)
|
Biotechnology
(1 time)
|
IGF (1 time)
MSCs (1 time)
TGF (1 time)
|
2008 Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Chondrocytes for Construction of Three-dimensional Cartilage Tissue.
|
| 55 |
polyarylate and a fast-degrading copolymer of lactic and glycolic acid
(1 time)
|
Pharmacology
(1 time)
|
---
|
2002 A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides.
|
| 56 |
polyethylenimine-poly(lactide-coglycolide)
(1 time)
|
Genetics, Medical
(1 time)
|
EPAS1 (1 time)
VEGF (1 time)
|
2015 PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
|
| 57 |
polyglucuronic acid
(1 time)
|
Biomedical Engineering
(1 time)
|
GAG (1 time)
|
2005 Effect of poly DL-lactic-co-glycolic acid mesh on a three-dimensional culture of chondrocytes.
|
| 58 |
polyglycolic acid and polylactide
(1 time)
|
Complementary Therapies
(1 time)
|
---
|
2005 [Blood vessel tissue engineering: seeding vascular smooth muscle cells and endothelial cells sequentially on biodegradable scaffold in vitro].
|
| 59 |
polyglycolic acid; lactide/glycolide copolymer
(1 time)
|
Rheumatology
(1 time)
|
ADM (1 time)
qPCR (1 time)
|
2013 Attachment, proliferation and collagen type I mRNA expression of human gingival fibroblasts on different biodegradable membranes.
|
| 60 |
polyglycolid-polylactid
(1 time)
|
Dentistry
(1 time)
|
HU (1 time)
|
2007 Bone formation after sinus augmentation with engineered bone.
|
| 61 |
polylactic acid-co-glycoside
(1 time)
|
Pharmacology
(1 time)
|
alpha-SMA (1 time)
Gyp (1 time)
TGF-beta (1 time)
|
2021 Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism.
|
| 62 |
polylactic/glycolic acid sponge
(1 time)
|
Orthopedics
(1 time)
|
ABG (1 time)
CT (1 time)
|
1998 Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
|
| 63 |
PolyLactide Glycolide Acid
(1 time)
|
Dentistry
(1 time)
|
PLLA (1 time)
|
2014 [Reaction of bone tissue elements on synthetic bioresorbable materials based on lactic and glycolic acids].
|
| 64 |
polymer and a biodegradable
(1 time)
|
Eye Diseases
(1 time)
|
5-FU (1 time)
AGV (1 time)
HEMA (1 time)
|
2015 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model.
|
| 65 |
polymer of glycolide and lactide
(1 time)
|
Biomedical Engineering
(1 time)
|
IM (1 time)
LNG (1 time)
s.c (1 time)
|
2003 [Studies on the toxicity of polymer of glycolide and lactide(PLGA) and the anti-fertility effect of levonorgestrel(LNG)].
|
| 66 |
polymer of lactic and glycolic acid
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2006 Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy.
|
| 67 |
polymeric biodegradable lactic-glycolic acid
(1 time)
|
Allergy and Immunology
(1 time)
|
EAE (1 time)
IFN (1 time)
IL (1 time)
|
2014 Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
|
| 68 |
Polymeric MP with D, L-lactic-co-glycolic acid
(1 time)
|
Chemistry
(1 time)
|
MP (1 time)
|
2018 Effect of excipients on encapsulation and release of insulin from spray-dried solid lipid microparticles.
|
| 69 |
posterior branch of the left gastric artery
(1 time)
|
Gastroenterology
(1 time)
|
LGA (1 time)
RGEA (1 time)
|
1990 [Relation between localization of gastric mucosal lesions and microvascular disturbance].
|
| 70 |
potentials, with a bio-adhesive agent -polylactic-co-glycolic acid
(1 time)
|
Complementary Therapies
(1 time)
|
NHMC (1 time)
PCNA (1 time)
PDI (1 time)
|
2010 Polymeric nanoparticle encapsulation of a naturally occurring plant scopoletin and its effects on human melanoma cell A375.
|
| 71 |
precise compositional analysis of copoly (DL-lactic/glycolic acid)
(1 time)
|
Chemistry
(1 time)
|
TMAH (1 time)
|
2001 Compositional analysis of copoly (DL-lactic/glycolic acid) (PLGA) by pyrolysis-gas chromatography/mass spectrometry combined with one-step thermally assisted hydrolysis and methylation in the presence of tetramethylammonium hydroxide.
|
| 72 |
prepared from copolymers of lactic and glycolic acid
(1 time)
|
Pharmacology
(1 time)
|
---
|
2009 A new class of inhibitors of peptide sorption and acylation in PLGA.
|
| 73 |
prepared from dl-lactide/glycolide copolymers
(1 time)
|
Chemistry
(1 time)
|
---
|
2006 Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
|
| 74 |
present study evaluated the size-dependency of DL lactide/glycolide copolymer
(1 time)
|
Pharmacology
(1 time)
|
FA-PLGA (1 time)
|
2002 Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.
|
| 75 |
previous work demonstrated that lactic/glycolic acid copolymer
(1 time)
|
Chemistry
(1 time)
|
SLN (1 time)
|
2009 The effect of glycolic acid monomer ratio on the emulsifying activity of PLGA in preparation of protein-loaded SLN.
|
| 76 |
Previously synthesized lactic/glycolic acid
(1 time)
|
Biomedical Engineering
(1 time)
|
---
|
1997 Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
|
| 77 |
previously-synthesized lactic/glycolic acid polymers
(1 time)
|
Biomedical Engineering
(1 time)
|
---
|
2001 Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation.
|
| 78 |
procedures using solvent-casting techniques with the same copoly(D,L-lactic) glycolic acid
(1 time)
|
Chemistry
(1 time)
|
D,L-lactic (1 time)
rhGH (1 time)
|
2005 A mathematical model for interpreting in vitro rhGH release from laminar implants.
|
| 79 |
prolonged anti-inflammatory action of DL-lactide/glycolide copolymer
(1 time)
|
Pharmacology
(1 time)
|
LA/GA (1 time)
PBS (1 time)
|
2002 Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit.
|
| 80 |
proper copoly(DL-lactic/glycolic)acid
(1 time)
|
Pharmacology
(1 time)
|
rhGH (1 time)
|
2003 Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique.
|
| 81 |
property on drug release, a novel reduction-sensitive amphiphilic copolymer
(1 time)
|
Nanotechnology
(1 time)
|
DTX (1 time)
|
2015 Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery.
|
| 82 |
Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer
(1 time)
|
Pharmacology
(1 time)
|
---
|
1999 Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.
|
| 83 |
rapamycin-polylactide-co-glycolide
(1 time)
|
Complementary Therapies
(1 time)
|
---
|
2007 [Pharmacodynamics of China-made rapamycin-polylactide-co-glycolide peripheral arterial eluting stent membrane: in vitro experiment].
|
| 84 |
tyroserleutide-poly(lactic-co-glycolic acid)
(1 time)
|
Nanotechnology
(1 time)
|
HCC (1 time)
|
2021 Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma.
|
A Search Service for Abbreviation / Long Form